Axcelead and Kyowa Kirin Started an Innovative Collaboration in Small-Molecule Drug Development
Tokyo, Japan, October 2, 2020 —Axcelead Drug Discovery Partners Inc.（Axcelead, President: Yoshinori Ikeura）and Kyowa Kirin Co., Ltd....
Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications
June 29,2020- Otsuka Pharmaceutical Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo, President: Makoto Inoue; Otsuka Pharmaceutical) and Axcelead Drug...
PassPort Technologies and Axcelead Drug Discovery Partners
Enter a comprehensive collaborative partnership in the field of drug discovery service using PassPort System, a new active...
Fujifilm and Axcelead Drug Discovery Partners begin collaborating to advance drug discovery solutions using iPSCs
To enhance the Process of Research and Development of Drug Candidates Tokyo/Kanagawa, July 10, 2019 ―FUJIFILM...
Transfer of All Axcelead Shares to Whiz Partners DDG Fund Completed
April 1, 2019 – Whiz Partners Inc. (hereinafter, “Whiz”), headquartered in Minato Ward, Tokyo, announced that it...
Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Fujisawa, Japan and Dublin, Ireland, October 4, 2018 – Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as...